{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:35:52Z","timestamp":1790706952224,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Funds for Innovation of Science and Technology, Fujian Province","award":["No. 2021Y9089"],"award-info":[{"award-number":["No. 2021Y9089"]}]},{"name":"University-Industry Research Joint Innovation Project of Science and Technology, Fujian Province","award":["No. 2023Y4018"],"award-info":[{"award-number":["No. 2023Y4018"]}]},{"name":"The National Key Research and Development Program of China during the 14th Five-Year Plan Period","award":["2023YFC2411603"],"award-info":[{"award-number":["2023YFC2411603"]}]},{"name":"The National Key Research and Development Program of China during the 14th Five-Year Plan Period","award":["2023YFC2411603"],"award-info":[{"award-number":["2023YFC2411603"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11102-025-01552-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:51:23Z","timestamp":1751352683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["FAP as a prognostic biomarker and radiomics-based predictor of angiogenesis-associated recurrence in Adamantinomatous craniopharyngioma"],"prefix":"10.1007","volume":"28","author":[{"given":"Qin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"3","key":"1552_CR1","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1210\/endrev\/bnac035","volume":"44","author":"JR Apps","year":"2023","unstructured":"Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP (2023) Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev 44(3):518\u2013538","journal-title":"Endocr Rev"},{"issue":"2","key":"1552_CR2","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1097\/SCS.0000000000005136","volume":"30","author":"M Kili\u00e7","year":"2019","unstructured":"Kili\u00e7 M, Can SM, \u00d6zdemir B, Tanik C (2019) Management of craniopharyngioma. J Craniofac Surg 30(2):e178\u2013e183","journal-title":"J Craniofac Surg"},{"issue":"1","key":"1552_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","volume":"5","author":"HL M\u00fcller","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primers 5(1):75","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"1552_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/er.2013-1115","volume":"35","author":"HL M\u00fcller","year":"2014","unstructured":"M\u00fcller HL (2014) Craniopharyngioma. Endocr Rev 35(3):513\u2013543","journal-title":"Endocr Rev"},{"issue":"4","key":"1552_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.otc.2011.06.015","volume":"44","author":"AC Stamm","year":"2011","unstructured":"Stamm AC, Vellutini E, Balsalobre L (2011) Craniopharyngioma. Otolaryngol Clin North Am 44(4):937\u201352","journal-title":"Otolaryngol Clin North Am"},{"key":"1552_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1172-2-18","volume":"2","author":"MR Garnett","year":"2007","unstructured":"Garnett MR, Puget S, Grill J, Sainte-Rose C (2007) Craniopharyngioma. Orphanet J Rare Dis 2:18","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1552_CR7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4103\/0028-3886.344661","volume":"70","author":"GS Harsha","year":"2022","unstructured":"Harsha GS, Dabadghao P, Sudhanshu S (2022) Long-term outcomes of paediatric-onset craniopharyngioma: a retrospective analysis from a tertiary care Centre in North India. Neurol India 70(2):600\u2013605","journal-title":"Neurol India"},{"issue":"4","key":"1552_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.23736\/S0391-1977.17.02615-3","volume":"42","author":"HL M\u00fcller","year":"2017","unstructured":"M\u00fcller HL (2017) Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients. Minerva Endocrinol 42(4):356\u2013375","journal-title":"Minerva Endocrinol"},{"issue":"9","key":"1552_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S2213-8587(23)00162-6","volume":"11","author":"HW Gan","year":"2023","unstructured":"Gan HW, Morillon P, Albanese A, Aquilina K, Chandler C, Chang YC, Drimtzias E, Farndon S, Jacques TS, Korbonits M, Kuczynski A, Limond J, Robinson L, Simmons I, Thomas N, Thomas S, Thorp N, Vargha-Khadem F, Warren D, Zebian B, Mallucci C, Spoudeas HA (2023) National UK guidelines for the management of paediatric craniopharyngioma. Lancet Diabetes Endocrinol 11(9):694\u2013706","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1552_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11060-021-03906-4","volume":"156","author":"F Henderson Jr","year":"2022","unstructured":"Henderson F Jr, Schwartz TH (2022) Update on management of craniopharyngiomas. J Neurooncol 156(1):97\u2013108","journal-title":"J Neurooncol"},{"issue":"9\u201310","key":"1552_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1159\/000504512","volume":"110","author":"HL M\u00fcller","year":"2020","unstructured":"M\u00fcller HL (2020) The diagnosis and treatment of craniopharyngioma. Neuroendocrinology 110(9\u201310):753\u2013766","journal-title":"Neuroendocrinology"},{"issue":"12","key":"1552_CR12","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s11912-023-01471-9","volume":"25","author":"S Gabay","year":"2023","unstructured":"Gabay S, Merchant TE, Boop FA, Roth J, Constantini S (2023) Shifting strategies in the treatment of pediatric craniopharyngioma. Curr Oncol Rep 25(12):1497\u20131513","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"1552_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/joim.13684","volume":"294","author":"EM Erfurth","year":"2023","unstructured":"Erfurth EM (2023) Craniopharyngioma-an update on metabolic and cognitive complications and new therapy. J Intern Med 294(3):269\u2013280","journal-title":"J Intern Med"},{"key":"1552_CR14","doi-asserted-by":"publisher","first-page":"1326595","DOI":"10.3389\/fonc.2023.1326595","volume":"13","author":"A Chen","year":"2023","unstructured":"Chen A, Ai M, Sun T (2023) Advances in the treatment of adamantinomatous craniopharyngioma: how to balance tumor control and quality of life in the current environment: a narrative review. Front Oncol 13:1326595","journal-title":"Front Oncol"},{"key":"1552_CR15","doi-asserted-by":"crossref","unstructured":"Agosti E, Zeppieri M, Antonietti S, Piazza A, Ius T, Fontanella MM, Fiorindi A, Panciani PP (2024) Advancing craniopharyngioma management: a systematic review of current targeted therapies and future perspectives. Int J Mol Sci 25(2):743","DOI":"10.3390\/ijms25020723"},{"issue":"3","key":"1552_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11102-022-01212-4","volume":"25","author":"P Iglesias","year":"2022","unstructured":"Iglesias P (2022) Targeted therapies in the medical management of craniopharyngioma. Pituitary 25(3):383\u2013392","journal-title":"Pituitary"},{"issue":"5","key":"1552_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrendo.2016.217","volume":"13","author":"HL M\u00fcller","year":"2017","unstructured":"M\u00fcller HL, Merchant TE, Puget S, Martinez-Barbera JP (2017) New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol 13(5):299\u2013312","journal-title":"Nat Rev Endocrinol"},{"key":"1552_CR18","doi-asserted-by":"publisher","first-page":"599888","DOI":"10.3389\/fonc.2020.599888","volume":"10","author":"G Ma","year":"2020","unstructured":"Ma G, Kang J, Qiao N, Zhang B, Chen X, Li G, Gao Z, Gui S (2020) Non-invasive radiomics approach predict invasiveness of adamantinomatous craniopharyngioma before surgery. Front Oncol 10:599888","journal-title":"Front Oncol"},{"key":"1552_CR19","doi-asserted-by":"crossref","unstructured":"Chen B, Chen C, Zhang Y, Huang Z, Wang H, Li R, Xu J (2022) Differentiation between germinoma and craniopharyngioma using radiomics-based machine learning. J Pers Med 12(1):45","DOI":"10.3390\/jpm12010045"},{"issue":"1","key":"1552_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA (2021) Diversity and biology of cancer-associated fibroblasts. Physiol Rev 101(1):147\u2013176","journal-title":"Physiol Rev"},{"issue":"1","key":"1552_CR21","doi-asserted-by":"publisher","first-page":"11568","DOI":"10.1038\/s41598-023-38768-5","volume":"13","author":"SK Pemmasani","year":"2023","unstructured":"Pemmasani SK, Atmakuri S, Acharya A (2023) Genome-wide polygenic risk score for type 2 diabetes in Indian population. Sci Rep 13(1):11568","journal-title":"Sci Rep"},{"issue":"2","key":"1552_CR22","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7150\/thno.60540","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, Li X, Zhou W, Li J, Li Z, Bai C, Zhao L, Han Q, Zhao RC, Wang X (2022) Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics 12(2):620\u2013638","journal-title":"Theranostics"},{"issue":"3","key":"1552_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, Engler S, Haberecker M, R\u00fcschoff JH, Moch H, de Souza N, Bodenmiller B (2024) Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell 42(3):396-412.e5","journal-title":"Cancer Cell"},{"issue":"2","key":"1552_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18(2):99\u2013115","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"1552_CR25","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s13346-023-01308-9","volume":"13","author":"S Shahvali","year":"2023","unstructured":"Shahvali S, Rahiman N, Jaafari MR, Arabi L (2023) Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy. Drug Deliv Transl Res 13(7):2041\u20132056","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"1552_CR26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.32193","volume":"146","author":"M Nurmik","year":"2020","unstructured":"Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E (2020) In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer 146(4):895\u2013905","journal-title":"Int J Cancer"},{"issue":"3","key":"1552_CR27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM (2020) The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev 39(3):783\u2013803","journal-title":"Cancer Metastasis Rev"},{"key":"1552_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/ITT.S291767","volume":"10","author":"R Bughda","year":"2021","unstructured":"Bughda R, Dimou P, D\u2019Souza RR, Klampatsa A (2021) Fibroblast activation protein (FAP)-targeted CAR-T cells: launching an attack on tumor stroma. Immunotargets Ther 10:313\u2013323","journal-title":"Immunotargets Ther"},{"issue":"14","key":"1552_CR29","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, Dang Y, Chu Y, Fan J, He R (2016) FAP promotes Immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res 76(14):4124\u20134135","journal-title":"Cancer Res"},{"issue":"11","key":"1552_CR30","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","volume":"49","author":"D Zboralski","year":"2022","unstructured":"Zboralski D, Hoehne A, Bredenbeck A, Schumann A, Nguyen M, Schneider E, Ungewiss J, Paschke M, Haase C, von Hacht JL, Kwan T, Lin KK, Lenore J, Harding TC, Xiao J, Simmons AD, Mohan AM, Beindorff N, Reineke U, Smerling C, Osterkamp F (2022) Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy. Eur J Nucl Med Mol Imaging 49(11):3651\u20133667","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1552_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40644-023-00598-z","volume":"23","author":"A Ar\u00e7ay \u00d6zt\u00fcrk","year":"2023","unstructured":"Ar\u00e7ay \u00d6zt\u00fcrk A, Flamen P (2023) FAP-targeted PET imaging in gastrointestinal malignancies: a comprehensive review. Cancer Imaging 23(1):79","journal-title":"Cancer Imaging"},{"issue":"10","key":"1552_CR32","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1016\/j.ymthe.2023.08.018","volume":"31","author":"KP Hartmann","year":"2023","unstructured":"Hartmann KP, van Gogh M, Freitag PC, Kast F, Nagy-Davidescu G, Borsig L, Pl\u00fcckthun A (2023) FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment. Mol Ther 31(10):2914\u20132928","journal-title":"Mol Ther"},{"key":"1552_CR33","doi-asserted-by":"publisher","first-page":"216905","DOI":"10.1016\/j.canlet.2024.216905","volume":"592","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liu X, Ainiwan Y, Li M, Pan J, Chen Y, Xiao Z, Wang Z, Xiao X, Tang J, Zeng G, Liang J, Su X, Kungulli R, Fan Y, Lin Q, Liya A, Zheng Y, Chen Z, Xu C, Zhang H, Chen G (2024) Axl as a potential therapeutic target for adamantinomatous craniopharyngiomas: Based on single nucleus RNA-seq and spatial transcriptome profiling. Cancer Lett 592:216905","journal-title":"Cancer Lett"},{"issue":"7","key":"1552_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/CM9.0000000000002774","volume":"137","author":"X Wang","year":"2024","unstructured":"Wang X, Zhao C, Lin J, Liu H, Zeng Q, Chen H, Wang Y, Xu D, Chen W, Xu M, Zhang E, Lin D, Lin Z (2024) Multi-omics analysis of adamantinomatous craniopharyngiomas reveals distinct molecular subgroups with prognostic and treatment response significance. Chin Med J (Engl) 137(7):859\u2013870","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"1552_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s10143-023-02146-6","volume":"46","author":"Y Chen","year":"2023","unstructured":"Chen Y, Liu X, Li M, Chen Y, Zhang H, Chen G (2023) Impact of three surgical approaches on the therapeutic efficacy of intraventricular craniopharyngiomas: a single-center retrospective analysis. Neurosurg Rev 46(1):238","journal-title":"Neurosurg Rev"},{"issue":"1","key":"1552_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-022-00351-z","volume":"8","author":"HL M\u00fcller","year":"2022","unstructured":"M\u00fcller HL, Tauber M, Lawson EA, \u00d6zyurt J, Bison B, Martinez-Barbera JP, Puget S, Merchant TE, van Santen HM (2022) Hypothalamic syndrome. Nat Rev Dis Primers 8(1):24","journal-title":"Nat Rev Dis Primers"},{"key":"1552_CR37","doi-asserted-by":"publisher","first-page":"e1245","DOI":"10.1016\/j.wneu.2018.09.053","volume":"120","author":"JM Pascual","year":"2018","unstructured":"Pascual JM, Prieto R, Castro-Dufourny I, Mongardi L, Rosdolsky M, Strauss S, Carrasco R, Barrios L (2018) Craniopharyngiomas primarily involving the hypothalamus: a model of neurosurgical lesions to elucidate the neurobiological basis of psychiatric disorders. World Neurosurg 120:e1245\u2013e1278","journal-title":"World Neurosurg"},{"key":"1552_CR38","first-page":"123","volume":"13","author":"RA Jastania","year":"2020","unstructured":"Jastania RA, Saeed M, Al-Khalidi H, AlQuthami K, Nageeti TH, Al-Allaf FA, Valerie K, Taher MM (2020) Adamantinomatous craniopharyngioma in an adult: a case report with ngs analysis. Int Med Case Rep J 13:123\u2013137","journal-title":"Int Med Case Rep J"},{"issue":"6","key":"1552_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/neuonc\/noae015","volume":"26","author":"EW Prince","year":"2024","unstructured":"Prince EW, Apps JR, Jeang J, Chee K, Medlin S, Jackson EM, Dudley R, Limbrick D, Naftel R, Johnston J, Feldstein N, Prolo LM, Ginn K, Niazi T, Smith A, Kilburn L, Chern J, Leonard J, Lam S, Hersh DS, Gonzalez-Meljem JM, Amani V, Donson AM, Mitra SS, Bandopadhayay P, Martinez-Barbera JP, Hankinson TC (2024) Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis. Neuro Oncol 26(6):1109\u20131123","journal-title":"Neuro Oncol"},{"key":"1552_CR40","doi-asserted-by":"crossref","unstructured":"An W, Li S, An Y, Lin Z (2025) Molecular subtypes of adamantinomatous craniopharyngiomas. Neuro Oncol 27(5):1180\u20131192","DOI":"10.1093\/neuonc\/noaf030"},{"issue":"3","key":"1552_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s11102-013-0490-4","volume":"17","author":"CB Gon\u00e7alves","year":"2014","unstructured":"Gon\u00e7alves CB, Lima GA, Nogueira J, do Souto AA, Chimelli L, Taboada GF (2014) Subgaleal recurrence of craniopharyngioma of rapid growing pattern. Pituitary 17(3):214\u20139","journal-title":"Pituitary"},{"issue":"3","key":"1552_CR42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3171\/2012.6.JNS111885","volume":"117","author":"M Jakobs","year":"2012","unstructured":"Jakobs M, Orakcioglu B (2012) Ectopic recurrent craniopharyngioma of the frontal bone. J Neurosurg 117(3):490\u2013497","journal-title":"J Neurosurg"},{"key":"1552_CR43","doi-asserted-by":"crossref","unstructured":"Romani R, Niemel\u00e4 M, Celik O, Isarakul P, Paetau A, Hernesniemi J (2010) Ectopic recurrence of craniopharyngioma along the surgical route: case report and literature review. Acta Neurochir (Wien) 152(2):297\u2013302 (discussion 302)","DOI":"10.1007\/s00701-009-0415-1"},{"issue":"5","key":"1552_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00381-010-1375-8","volume":"27","author":"M Elfving","year":"2011","unstructured":"Elfving M, Lundgren J, Englund E, Str\u00f6mblad LG, Erfurth EM (2011) Ectopic recurrence of a craniopharyngioma in a 15-year-old girl 9 years after surgery and conventional radiotherapy: case report. Childs Nerv Syst 27(5):845\u2013851","journal-title":"Childs Nerv Syst"},{"key":"1552_CR45","doi-asserted-by":"crossref","unstructured":"Bikmaz K, Guerrero CA, Dammers R, Krisht AF, Husain MM (2009) Ectopic recurrence of craniopharyngiomas: case report. Neurosurgery 64(2):E382-3 (discussion E383)","DOI":"10.1227\/01.NEU.0000337078.60998.98"},{"issue":"9","key":"1552_CR46","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00381-009-0917-4","volume":"25","author":"EM Frangou","year":"2009","unstructured":"Frangou EM, Tynan JR, Robinson CA, Ogieglo LM, Vitali AM (2009) Metastatic craniopharyngioma: case report and literature review. Childs Nerv Syst 25(9):1143\u20131147","journal-title":"Childs Nerv Syst"},{"issue":"1\u20132","key":"1552_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10555-011-9340-x","volume":"31","author":"P Cirri","year":"2012","unstructured":"Cirri P, Chiarugi P (2012) Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev 31(1\u20132):195\u2013208","journal-title":"Cancer Metastasis Rev"},{"key":"1552_CR48","doi-asserted-by":"crossref","unstructured":"Yoshida GJ, Azuma A, Miura Y, Orimo A (2019) Activated fibroblast program orchestrates tumor initiation and progression; molecular mechanisms and the associated therapeutic strategies. Int J Mol Sci 20(9):2256","DOI":"10.3390\/ijms20092256"},{"issue":"19","key":"1552_CR49","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","volume":"72","author":"T Fiaschi","year":"2012","unstructured":"Fiaschi T, Marini A, Giannoni E, Taddei ML, Gandellini P, De Donatis A, Lanciotti M, Serni S, Cirri P, Chiarugi P (2012) Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res 72(19):5130\u20135140","journal-title":"Cancer Res"},{"issue":"1","key":"1552_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, Liu Z, Yang L, Jiang Q, Cheng Q, Luo P, Liu G (2023) Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer 22(1):159","journal-title":"Mol Cancer"},{"issue":"12","key":"1552_CR51","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1158\/2159-8290.CD-22-1467","volume":"13","author":"WH Hsu","year":"2023","unstructured":"Hsu WH, LaBella KA, Lin Y, Xu P, Lee R, Hsieh CE, Yang L, Zhou A, Blecher JM, Wu CJ, Lin K, Shang X, Jiang S, Spring DJ, Xia Y, Chen P, Shen JP, Kopetz S, DePinho RA (2023) Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression. Cancer Discov 13(12):2652\u20132673","journal-title":"Cancer Discov"},{"issue":"9","key":"1552_CR52","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16(9):582\u2013598","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1552_CR53","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","volume":"42","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Yu Y, Zhang Z, Li D, Liang Z, Wang L, Chen Y, Liang Y, Niu H (2023) Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1. J Exp Clin Cancer Res 42(1):316","journal-title":"J Exp Clin Cancer Res"},{"key":"1552_CR54","doi-asserted-by":"publisher","first-page":"116058","DOI":"10.1016\/j.biopha.2023.116058","volume":"171","author":"M Xu","year":"2024","unstructured":"Xu M, Zhao X, Wen T, Qu X (2024) Unveiling the role of KRAS in tumor immune microenvironment. Biomed Pharmacother 171:116058","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1552_CR55","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1158\/0008-5472.CAN-22-1890","volume":"83","author":"T Akiyama","year":"2023","unstructured":"Akiyama T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, Tan BJY, Yonemura A, Semba T, Yamasaki J, Komohara Y, Ohnishi K, Wei F, Fu L, Zhang J, Kitamura F, Yamashita K, Eto K, Iwagami S, Tsukamoto H, Umemoto T, Masuda M, Nagano O, Satou Y, Saya H, Tan P, Baba H, Ishimoto T (2023) Stromal reprogramming through dual PDGFR\u03b1\/\u03b2 blockade boosts the efficacy of anti-PD-1 immunotherapy in fibrotic tumors. Cancer Res 83(5):753\u2013770","journal-title":"Cancer Res"},{"issue":"36","key":"1552_CR56","doi-asserted-by":"publisher","first-page":"e2301257","DOI":"10.1002\/adma.202301257","volume":"35","author":"D Guo","year":"2023","unstructured":"Guo D, Ji X, Xie H, Ma J, Xu C, Zhou Y, Chen N, Wang H, Fan C, Song H (2023) Targeted reprogramming of vitamin B(3) metabolism as a nanotherapeutic strategy towards chemoresistant cancers. Adv Mater 35(36):e2301257","journal-title":"Adv Mater"},{"key":"1552_CR57","doi-asserted-by":"crossref","unstructured":"Sung JY, Lee JW (2024) Cancer-associated fibroblast subtypes reveal distinct gene signatures in the tumor immune microenvironment of vestibular schwannoma. Cells 13(19):1669","DOI":"10.3390\/cells13191669"},{"key":"1552_CR58","doi-asserted-by":"crossref","unstructured":"Miyazaki Y, Mori N, Akagi Y, Oda T, Kida YS (2022) Potential metabolite markers for pancreatic cancer identified by metabolomic analysis of induced cancer-associated fibroblasts. Cancers (Basel) 14(6):1375","DOI":"10.3390\/cancers14061375"},{"issue":"1","key":"1552_CR59","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R (2019) Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer 18(1):70","journal-title":"Mol Cancer"},{"key":"1552_CR60","doi-asserted-by":"crossref","unstructured":"Czekay RP, Cheon DJ, Samarakoon R, Kutz SM, Higgins PJ (2022) Cancer-associated fibroblasts: mechanisms of tumor progression and novel therapeutic targets. Cancers (Basel) 14(5)","DOI":"10.3390\/cancers14051231"},{"issue":"4","key":"1552_CR61","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s13402-021-00602-3","volume":"44","author":"J Majidpoor","year":"2021","unstructured":"Majidpoor J, Mortezaee K (2021) Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (Dordr) 44(4):715\u2013737","journal-title":"Cell Oncol (Dordr)"},{"issue":"6","key":"1552_CR62","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc1093","volume":"3","author":"G Bergers","year":"2003","unstructured":"Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401\u2013410","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1552_CR63","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L (2023) Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther 8(1):198","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1552_CR64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1385\/EP:16:4:355","volume":"16","author":"CM Dallago","year":"2005","unstructured":"Dallago CM, Oliveira MC, Barbosa-Coutinho LM, Ferreira NP (2005) Angiogenesis in craniopharyngiomas: microvascular density and tissue expression of the vascular endothelial growth factor (VEGF) and endostatin. Endocr Pathol 16(4):355\u2013362","journal-title":"Endocr Pathol"},{"key":"1552_CR65","doi-asserted-by":"crossref","unstructured":"Sun HI, Akgun E, Bicer A, Ozkan A, Bozkurt SU, Kurtkaya O, Koc DY, Pamir MN, Kilic T (2010) Expression of angiogenic factors in craniopharyngiomas: implications for tumor recurrence. Neurosurgery 66(4):744\u201350 (discussion 750)","DOI":"10.1227\/01.NEU.0000367553.65099.14"},{"issue":"3","key":"1552_CR66","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/cncr.10281","volume":"94","author":"S Vidal","year":"2002","unstructured":"Vidal S, Kovacs K, Lloyd RV, Meyer FB, Scheithauer BW (2002) Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome. Cancer 94(3):738\u2013745","journal-title":"Cancer"},{"issue":"1","key":"1552_CR67","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10856-012-4784-2","volume":"24","author":"O Karal-Yilmaz","year":"2013","unstructured":"Karal-Yilmaz O, Ozkan A, Akgun E, Kukut M, Baysal K, Avsar T, Kilic T (2013) Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis. J Mater Sci Mater Med 24(1):147\u2013153","journal-title":"J Mater Sci Mater Med"},{"issue":"6","key":"1552_CR68","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ando.2023.10.003","volume":"84","author":"A De Rosa","year":"2023","unstructured":"De Rosa A, Calvanese F, Ducray F, Vasiljevic A, Manet R, Raverot G, Jouanneau E (2023) First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: Case report and illustrative review. Ann Endocrinol (Paris) 84(6):727\u2013733","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"1552_CR69","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-012-0957-9","volume":"124","author":"CL Andoniadou","year":"2012","unstructured":"Andoniadou CL, Gaston-Massuet C, Reddy R, Schneider RP, Blasco MA, Le Tissier P, Jacques TS, Pevny LH, Dattani MT, Martinez-Barbera JP (2012) Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathol 124(2):259\u2013271","journal-title":"Acta Neuropathol"},{"issue":"28","key":"1552_CR70","doi-asserted-by":"publisher","first-page":"11482","DOI":"10.1073\/pnas.1101553108","volume":"108","author":"C Gaston-Massuet","year":"2011","unstructured":"Gaston-Massuet C, Andoniadou CL, Signore M, Jayakody SA, Charolidi N, Kyeyune R, Vernay B, Jacques TS, Taketo MM, Le Tissier P, Dattani MT, Martinez-Barbera JP (2011) Increased wingless (Wnt) signaling in pituitary progenitor\/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci USA 108(28):11482\u201311487","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1552_CR71","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1530\/EJE-21-1269","volume":"187","author":"JIS Mota","year":"2022","unstructured":"Mota JIS, Silva-J\u00fanior RMP, Martins CS, Bueno AC, Wildemberg LE, Antunes X, Ozaki JGO, Coeli-Lacchini FB, Garcia-Peral C, Oliveira AER, Santos AC, Moreira AC, Machado HR, Dos Santos MV, Colli LM, Gadelha MR, Antonini SRR, de Castro M (2022) Telomere length and Wnt\/\u03b2-catenin pathway in adamantinomatous craniopharyngiomas. Eur J Endocrinol 187(2):219\u2013230","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1552_CR72","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1007\/s00018-021-03798-7","volume":"78","author":"JM Gonzalez-Meljem","year":"2021","unstructured":"Gonzalez-Meljem JM, Martinez-Barbera JP (2021) Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis. Cell Mol Life Sci: CMLS 78(10):4521\u20134544","journal-title":"Cell Mol Life Sci: CMLS"},{"issue":"32","key":"1552_CR73","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2217\/fon-2020-0095","volume":"16","author":"F Zhang","year":"2020","unstructured":"Zhang F, Cui JY, Gao HF, Yu H, Gao FF, Chen JL, Chen L (2020) Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12\/CXCR4 axis. Future Oncol (London, England) 16(32):2619\u20132633","journal-title":"Future Oncol (London, England)"},{"issue":"10","key":"1552_CR74","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4161\/cbt.29924","volume":"15","author":"FM Zi","year":"2014","unstructured":"Zi FM, He JS, Li Y, Wu C, Wu WJ, Yang Y, Wang LJ, He DH, Yang L, Zhao Y, Zheng GF, Han XY, Huang H, Yi Q, Cai Z (2014) Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through \u03b2-catenin signaling pathway. Cancer Biol Ther 15(10):1413\u20131422","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"1552_CR75","first-page":"661","volume":"44","author":"J Xie","year":"2021","unstructured":"Xie J, Qi X, Wang Y, Yin X, Xu W, Han S, Cai Y, Han W (2021) Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt\/\u03b2-catenin pathway. Cell Oncol (Dordrecht, Netherlands) 44(3):661\u2013671","journal-title":"Cell Oncol (Dordrecht, Netherlands)"},{"key":"1552_CR76","doi-asserted-by":"publisher","first-page":"156676","DOI":"10.1016\/j.cyto.2024.156676","volume":"180","author":"X Lu","year":"2024","unstructured":"Lu X, Xu X, Zhou M, Ge J, Chen L, Yu W, Wang H (2024) IL-17A-induced cancer-associated fibroblasts releases CXCL12 to promote lung adenocarcinoma progression via Wnt\/\u03b2-catenin signaling pathway. Cytokine 180:156676","journal-title":"Cytokine"},{"issue":"9","key":"1552_CR77","doi-asserted-by":"publisher","first-page":"e31344","DOI":"10.1002\/jcp.31344","volume":"239","author":"Z Su","year":"2024","unstructured":"Su Z, Lu C, Zhang F, Liu H, Li M, Qiao M, Zou X, Luo D, Li H, He M, Se H, Jing J, Wang X, Yang H, Yang H (2024) Cancer-associated fibroblasts-secreted exosomal miR-92a-3p promotes tumor growth and stemness in hepatocellular carcinoma through activation of Wnt\/\u03b2-catenin signaling pathway by suppressing AXIN1. J Cell Physiol 239(9):e31344","journal-title":"J Cell Physiol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01552-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-025-01552-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01552-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:53:47Z","timestamp":1757206427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-025-01552-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1007\/s11102-025-01552-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"23 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent for publication. All clinical craniopharyngioma samples and clinical data were collected at the Nanfang Hospital and all patients have signed informed consent to participate in the study according to the ethical protocols of the Ethics Committee of Nanfang Hospital, Southern Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"80"}}